类叶牡丹提取物通过FAK/PI3K通路抑制胃癌HGC-27细胞
本研究探讨类叶牡丹提取物(CRME)抗胃癌的分子机制。体外实验显示CRME抑制HGC-27细胞增殖、迁移和血管生成,诱导凋亡和自噬体形成并阻滞细胞周期于G0/G1期;体内移植瘤模型证实其抑制肿瘤生长。HPLC鉴定Cauloside A和C为成分,Western blot表明CRME通过降低FAK磷酸化调控PI3K/AKT通路。
要点
- CRME抑制胃癌HGC-27细胞增殖、迁移和血管生成。
- CRME诱导凋亡、促进自噬体形成并阻滞细胞周期于G0/G1期。
- CRME通过降低FAK磷酸化调控PI3K/AKT通路。
核心结论
- CRME抗肿瘤成分Cauloside A和Cauloside C通过降低FAK磷酸化水平调控PI3K/AKT信号通路,抑制HGC-27细胞肿瘤进展。
研究设计与样本
- 采用HPLC对CRME进行定性分析,并通过系列细胞功能实验和异种移植瘤模型评价其抗肿瘤作用。
主要发现
- CRME显著抑制HGC-27细胞增殖、迁移和血管生成能力。
- 异种移植瘤模型显示CRME在体内抑制细胞增殖。
- Annexin V-FITC/PI双染和PI单染显示CRME诱导细胞凋亡并将细胞周期阻滞于G0/G1期。
- AO染色显示CRME促进自噬体形成并抑制自噬流。
- HPLC表明Cauloside A和Cauloside C是CRME的成分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Caulophyllumrobustum Maxim extract (CRME), as recorded in traditional Chinese medicine, has the function of dispelling Feng, regulating Qi and dredging collaterals, promoting blood circulation and regulating menstruation, gingering up and relieving pain, clearing heat simultaneously detoxifying, lowering blood pressure and hemostasis. CRME is often used as Chinese materia medica preparation for rheumatoid arthritis, traumatic injury, irregular menstruation, abdominal pain, and hypertension treatment. Since gastric cancer (GC) existed as a health problem of human over the years, we are committed to the development of potential components of Chinese herbal medicine curing cancer, and we found CRME is expected to be one of the effective anti-tumor traditional Chinese medicine preparations. AIMS OF THE STUDY: To investigate the molecular mechanisms of CRME anticancer effects and the potential links between CRME and FAK. MATERIALS AND METHODS: Caulophyllumrobustum Maxim was extracted to obtain CRME, high-performance liquid chromatography (HPLC) was used for qualitative analysis. Information about CRME was collected from traditional Chinese medicine records and local surveys unpublished internationally. Series of cellular function experiments were applied to detect cell proliferation, migration, apoptosis, autophagy, cell cycle, angiogenesis. The xenograft model is employed in vivo. RESULTS: CRME can significantly inhibit HGC-27 cells on proliferation, migration and angiogenic capacity. Xenograft model indicated CRME inhibited cell proliferation in vivo. Annexin V-FITC/PI double staining assay and PI single staining assay depicted that CRME induces cell apoptosis, and arrests cell cycle at G0/G1 phase. AO (acridine orange) staining assay showed that CRME promoted autophagosome formation and inhibited autophagic flow. HPLC indicated Cauloside A and Cauloside C are components of CRME. Western blot indicated that FAK/PI3K signaling pathway is critical in the inhibition of CRME on HGC-27 cells. CONCLUSIONS: The anti-tumor components of CRME, Cauloside A and Cauloside C, inhibited tumor progression in HGC-27 cells. This inhibition is achieved by decreasing the phosphorylation levels of FAK, thereby modulating PI3K/AKT signaling pathway.
引用
- Cui M, Yao G, Zhang Y, et al. The molecular mechanisms of Caulophyllum robustum Maxim extract inhibition by regulating FAK/PI3K signaling pathway in gastric cancer HGC-27 cells. J Ethnopharmacol. 2024. PMID: 39369918. doi:10.1016/j.jep.2024.118867
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。